Single‐Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in Osteosarcoma
International Journal of Genomics · 2026-01 · 2026 (1)
DOI: 10.1155/ijog/4040246 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Genomics, online erschienen am 18.07.2026. Verfasst von Hui Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shaanxi Provincial People's Hospital, Xi'an City, Shaanxi Province, China. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Basic Research Program of Shaanxi Province.
Abstract (Originalsprache)
Background
Osteosarcoma is the most prevalent primary malignant bone tumor predominantly affecting children and adolescents, yet prognosis for metastatic disease remains dismal. Understanding the cellular complexity within the tumor microenvironment is essential for developing targeted therapeutic strategies.
Methods
We performed comprehensive single‐cell RNA sequencing analysis on an osteosarcoma tissue sample (GSM4952363) using the Seurat pipeline (v4.3.0). Following rigorous quality control (200–6000 genes per cell, < 15% mitochondrial reads), cells were filtered for downstream analysis. Dimensionality reduction (PCA and UMAP) and unsupervised clustering (Louvain algorithm, resolution = 0.8) identified seven distinct cellular clusters. Differential expression analysis (Wilcoxon rank‐sum test, |log₂FC| > 0.25, adjusted p < 0.05) identified cluster‐specific markers, while Gene Ontology and KEGG pathway enrichment analyses (clusterProfiler, adjusted p < 0.05) revealed functional programs. Four candidate genes (F11, ACRP2, LEPR, and POSTN) were selected for validation by quantitative real‐time PCR (mRNA level) and ELISA (protein level) in MG‐63 osteosarcoma cells compared to hFOB 1.19 normal osteoblasts.
Results
Single‐cell transcriptomic profiling identified seven distinct cellular clusters within the osteosarcoma microenvironment, including macrophages (Cluster 0, 28.0%), osteoblasts (Cluster 1, 24.2%), fibroblasts (Cluster 2, Fibro_COMP, 14.7%), proliferating cells (Cluster 3, 12.3%), osteoclasts (Cluster 4, 11.6%), monocytes (Cluster 5, 6.3%), and T cells (Cluster 6, 2.9%). Functional enrichment analysis highlighted activation of PI3K‐Akt signaling, focal adhesion, and extracellular matrix organization as core pathways. qRT‐PCR validation (mRNA level) demonstrated that F11 was significantly downregulated (0.31 ± 0.04 vs. 1.00 ± 0.07, 69% reduction, p < 0.001), whereas ACRP2 (2.87 ± 0.33‐fold), LEPR (4.52 ± 0.48‐fold), and POSTN (6.23 ± 0.57‐fold) were significantly upregulated (all p < 0.001). ELISA validation (protein level) confirmed consistent trends: F11 protein decreased by 65% (0.35 ± 0.05 vs. 1.00 ± 0.08, p < 0.001), whereas ACRP2 (2.64 ± 0.29‐fold), LEPR (4.18 ± 0.44‐fold), and POSTN (5.89 ± 0.53‐fold) protein levels were elevated (all p < 0.001). Among the four candidates, POSTN exhibited the most pronounced changes at both mRNA and protein levels, suggesting its involvement in osteosarcoma matrix remodeling.
Conclusions
This study provides a single‐cell transcriptomic atlas of the osteosarcoma microenvironment, revealing substantial cellular heterogeneity. The differentially expressed genes F11, ACRP2, LEPR, and POSTN represent candidate biomarkers that warrant further investigation for their potential roles in osteosarcoma biology and as putative therapeutic targets.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Shaanxi Provincial People's Hospital, Xi'an City, Shaanxi Province, China.
- Department of Orthopaedics, Yuechi Hospital of T.C.M., Guang'an City, Sichuan Province, China.
- Department of Orthopedics, Jiujiang City Key Laboratory of Cell Therapy, Jiujiang No. 1 People's Hospital, Jiujiang City, Jiangxi Province, China, jxjjsdyrmyy.cn.
ORCID-Profile: Hui Li, Changjiang Sun, Minjie Yang
Förderung
- Natural Science Basic Research Program of Shaanxi Province
Zitieren
APA
Li, H., Sun, C., & Yang, M. (2026). Single‐Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in Osteosarcoma. International Journal of Genomics, 2026(1). https://doi.org/10.1155/ijog/4040246
Vancouver
Li H, Sun C, Yang M. Single‐Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in Osteosarcoma. International Journal of Genomics. 2026;2026(1). doi:10.1155/ijog/4040246
BibTeX
@article{Li2026,
author = {Li, Hui and Sun, Changjiang and Yang, Minjie},
title = {Single‐Cell Transcriptomic Profiling Reveals Cellular Heterogeneity and Identifies Novel Therapeutic Targets in Osteosarcoma},
journal = {International Journal of Genomics},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijog/4040246}
}
EUVIMED